<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" id="no-js"><!-- InstanceBegin template="/Templates/ContentPage_Wide.dwt" codeOutsideHTMLIsLocked="false" -->

<head>
<meta http-equiv="X-UA-Compatible" content="IE=edge" />
<!-- InstanceBeginEditable name="title-tag" -->
<title>Published Reports of Delayed Hemolytic Anemia After Treatment with Artesunate for Severe Malaria &#8212; Worldwide, 2010&#8211;2012</title>
<!-- InstanceEndEditable --><!-- InstanceBeginEditable name="meta-data" -->
<meta name="description"    content="" />
<meta name="Keywords"       content="" />
<meta name="DC.Subject"     content="" />
<meta name="DC.Language"    scheme="ISO 639-2" content="eng" />
<meta name="Volume" content="62" />
<meta name="Issue" content="01" />
<meta name="Page" content="5" />
<meta name="Month" content="01" />
<meta name="Day" content="11" />
<meta name="Year" content="2013" />
<meta name="Issue_Num" content="1" />
<meta name="MMWR_Type" content="mm" />
<meta name="Date" content="2013-01-11" />
<script language="Javascript" type="text/javascript">
<!--
var img_folder = '../../images/';
var deRef="../../";
var reportTitle = 'Weekly';
var reportDate = 'January 11, 2013 / 62(01);5-8';
//-->
</script>

<script language="javascript1.2" type="text/javascript" src="https://www.cdc.gov/mmwr/scripts/scripts.js"></script>
<script language="javascript1.2" type="text/javascript" src="https://www.cdc.gov/scripts/scripts_reports.js"></script>
<!-- InstanceEndEditable --><!-- InstanceParam name="class" type="text" value="" --><!-- InstanceParam name="localFilesPath" type="text" value="mmwr" --><!-- InstanceParam name="content" type="boolean" value="true" --><!-- InstanceParam name="optionSpanish" type="boolean" value="false" --><!-- InstanceParam name="optionalFeatures" type="boolean" value="false" --><!-- InstanceParam name="optionalBreadCrumbs" type="boolean" value="true" --><!-- InstanceParam name="OptionalLocalSearch" type="boolean" value="false" --><!-- InstanceParam name="OptionalLocalA-Z" type="boolean" value="false" --><!-- InstanceParam name="optionalExtra" type="boolean" value="false" --><!-- InstanceParam name="JqueryUI" type="boolean" value="false" --><!-- InstanceParam name="JqueryUiAccordion" type="boolean" value="false" --><!-- InstanceParam name="JqueryUiCarousel" type="boolean" value="false" --><!-- InstanceParam name="JqueryUiDatePicker" type="boolean" value="false" --><!-- InstanceParam name="JqueryUiTabs" type="boolean" value="false" --><!-- InstanceParam name="dojoLibrary" type="boolean" value="false" -->

<meta http-equiv="content-type" content="text/html; charset=utf-8" />

<meta name="template.version" content="2.7.1.4" />
<!-- @package: TemplatePackage 'B' @version: "2.7.1.4" -->
<style type="text/css" media="screen">empty{color:#000};@import "https://www.cdc.gov/mmwr/local/B/css/designview/designTime.css"/**/;</style>
<link rel="stylesheet" href="../../../TemplatePackage/css/B/reset.css" type="text/css" media="screen" />
<link rel="stylesheet" href="../../../TemplatePackage/css/B/newMods.css" type="text/css" media="screen" />
<link rel="stylesheet" href="../../../TemplatePackage/css/B/print.css" type="text/css" media="print" />

<!-- compliance patch for microsoft browsers -->
<!--[if IE 6]>
<link rel="stylesheet" type="text/css" href="/TemplatePackage/css/B/ie6_fixes.css" />
<![endif]-->

<!--[if IE 7]>
<link rel="stylesheet" type="text/css" href="/TemplatePackage/css/B/ie7_fixes.css" />
<![endif]-->

<!--[if IE 8]>
<link rel="stylesheet" type="text/css" href="/TemplatePackage/css/B/ie8_fixes.css" />
<![endif]-->
<!-- /end compliance patch for microsoft browsers --><!-- JS below -->
<script type="text/javascript">(function(H){H.id=H.id.replace('no-','')})(document.documentElement)</script>
<script type="text/javascript" src="../../../TemplatePackage/js/B/jquery.js"></script>
<script type="text/javascript" src="../../../TemplatePackage/js/B/jquery.watermark.js"></script>
<script type="text/javascript" src="../../../TemplatePackage/js/B/common.js"></script>
<script type="text/javascript" src="../../../TemplatePackage/js/B/startup.js"></script>
<script type="text/javascript" src="../../../TemplatePackage/js/B/socialMedia.js"></script>
<script type="text/javascript" src="../../../TemplatePackage/js/B/blocks-ie.js"></script>
<script type="text/javascript" src="../../../TemplatePackage/js/B/video.js"></script>
<script type="text/javascript" src="../../../TemplatePackage/js/B/navScripts.js"></script>
<script type="text/javascript" src="../../../TemplatePackage/js/B/govdelivery.js"></script>
<script type="text/javascript" src="../../../TemplatePackage/js/B/anchor.js"></script>
<script type="text/javascript" src="../../../TemplatePackage/js/B/syndicateThisPage.js"></script>
<script type="text/javascript" src="../../../TemplatePackage/js/B/css-include.js"></script>
<script type="text/javascript" src="../../../TemplatePackage/3.0/js/libs/moment/moment.min.js"></script>

<!-- compliance patch for microsoft browsers -->
<!--[if IE 6]>
<script type="text/javascript" src="/TemplatePackage/js/B/pngfix.js"></script>
<script type="text/javascript" src="/TemplatePackage/js/B/blocks-ie6.js"></script>
<![endif]-->

<!--[if lte IE 8]>
<script type="text/javascript" src="/TemplatePackage/js/B/jquery.curvycorners.js"></script>
<![endif]-->

<script type="text/javascript" src="../../../TemplatePackage/js/B/cdc-gridCompatibility.js"></script>

<link rel="shortcut icon" href="../../../TemplatePackage/images/home/favicon.ico" />
<link rel="home" href="../../../index.html" title="Home" />

<!-- Begin Survey scripts -->
<script type="text/javascript" src="../../../JScript/foresee/foresee-trigger.js"></script>
<script type="text/javascript" src="../../../JScript/foresee-variables.js"></script>
<!-- End Survey scripts -->


<!--[if IE]>
<script defer language="javascript" type="text/javascript">
		var cdcLeftNav = new CDC.LeftNav("nav-primary");
		cdcLeftNav.render();
</script>
<![endif]-->
<!--[if ! IE]><!-->
<script language="javascript" type="text/javascript">
$().ready(function(){
		var cdcLeftNav = new CDC.LeftNav("nav-primary");
		cdcLeftNav.render();
});
</script>
<!--<![endif]-->

<!-- InstanceBeginEditable name="local-css" -->
<link href="https://www.cdc.gov/mmwr/local/B/css/local.css" rel="stylesheet" type="text/css" media="screen" />
<!-- InstanceEndEditable -->
<!-- InstanceBeginEditable name="mmwr-css" -->
<link href="https://www.cdc.gov/mmwr/local/B/css/mmwr2.css" rel="stylesheet" type="text/css" media="screen" />
<!-- InstanceEndEditable -->
</head>
<body id="contentPageWide" class=" widePage v270">

<div id="skipmenu">
	<a href="mm6201a2.htm@s_cid=mm6201a2_w.html#searchBox" class="skippy" title="Skip to search">Skip directly to search</a>
	<a href="mm6201a2.htm@s_cid=mm6201a2_w.html#az" class="skippy" title="Skip to A to Z list">Skip directly to A to Z list</a>
	<a href="mm6201a2.htm@s_cid=mm6201a2_w.html#content-main" class="skippy" title="Skip to content">Skip directly to site content</a>
</div>
<div id="wrapper">
<div id="wrapper-inner">
<div id="branding">
    <span id="homeward"><a href="../../../index.html" title="Return to the CDC Home Page">CDC Home</a></span>
<div id="branding-logo">
	<div id="branding-logoImage"><img src="../../../TemplatePackage/images/cdcHeaderLogo.gif" width="470" height="47" alt="CDC. Centers for Disease Control and Prevention. CDC 24/7: Saving Lives. Protecting People." border="0" /><a href="../../../index.html" title="CDC 24/7: Saving Lives. Protecting People.&trade;"><span>CDC 24/7: Saving Lives. Protecting People.&trade;</span></a></div>

    	<div id="searchForm" class="searchResize"><a name="search"></a>
		<form id="searchCDC" method="get" action="https://search.cdc.gov/search">
			<fieldset>
				<div id="cdc-Query">
					<label for="searchBox" class="overlabel search">Search The CDC</label>
					<input id="searchBox" class="searchBox" name="query" maxlength="256" type="text" />
				</div>
				<div id="cdc-Submit">
					<!-- label for="searchButton" class="searchButton">Search Button</label -->
					<input id="searchButton" class="searchButton" src="../../../TemplatePackage/images/home/search_button.gif" name="searchButton" alt="Search" type="image" />
					<input name="action" value="search" type="hidden" />
				</div>
				<input type="hidden" name="utf8" value="&#x2713;"/>
				<input type="hidden" name="affiliate" value="cdc-main"/>
			</fieldset>
		</form>
	</div>
    </div>
<noscript>
<div class="noscript"> Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: <a href="../../../Other/about_cdcgov.html" title="Browser requirements for CDC.gov">About CDC.gov</a>.</div>
</noscript>
<!--<div id="emergency-alert">
<h1></h1> 
<p></p>
<a href="#"></a>
</div>-->
</div>

<div id="content">
<div id="topic-title"><!-- InstanceBeginEditable name="topic-title" -->
<h2><a href="../../../mmwr.1.html">Morbidity and Mortality Weekly Report (<i>MMWR</i>)</a></h2>
<!-- InstanceEndEditable -->
    </div>
<div id="content-inner">
        <div class="pageOptions-horizontal">
            <!-- ########## BREADCRUMBS START HERE ########## -->
                <!-- InstanceBeginEditable name="breadcrumbs" -->
                <div id="breadBox">
	<ul id="breadcrumbs">
		<li class="firstChild"><a href="../../../mmwr.1.html"><i>MMWR</i></a></li>
		<!--<li><a href="#">Another Breadcrumb</a></li> -->
	</ul>
	    <p id="return-link">&nbsp;</p>
</div>

                <!-- InstanceEndEditable -->
                <div class="pageOptions-inner">
                    <ul class="forWide">
                        <li class="print"><a href="javascript:window.print();" title="Print page.">&nbsp;</a></li>

                        <!-- InstanceBeginEditable name="local-options" -->
                        <li class="subscribe"><a href="http://service.govdelivery.com/service/subscribe.html?code=USCDC_921" title="Get Email Updates from MMWR">&nbsp;</a></li>
<li class="rss"><a href="../../rss/mmwr.xml" title="Subscribe to MMWR RSS feeds">&nbsp;</a></li>
<li class="podcast"><a href="../../mmwrpodcasts.html" title="Listen to MMWR podcasts">&nbsp;</a></li>
            <li><a href="https://www.cdc.gov/mmwr/pdf/wk/mm6201.pdf">&nbsp;</a></li>
            <!-- InstanceEndEditable -->
        </ul>
  </div>
</div>
<div id="socialMediaContainer">
	<div class="share_container noLinking">
	 	<a class="share_button_facebook" title="Facebook" href="mm6201a2.htm@s_cid=mm6201a2_w.html#"><span id="share_facebook" class="facebookRecommend"></span></a>
	 	<a class="share_button_twitter" title="Twitter" href="mm6201a2.htm@s_cid=mm6201a2_w.html#"><span id="share_twitter" class="twitterTweet"></span></a>
		<a class="share_button noLinking" href="mm6201a2.htm@s_cid=mm6201a2_w.html#socialMediaContainer"><img src="../../../TemplatePackage/images/social/sm-plus.gif" alt="Share" /><span class="shareButtonEn">Share</span><span class="shareButtonEs">Compartir</span></a>
	</div>
</div>

<!-- InstanceBeginEditable name="include-contactInfo1" -->
<div class="contactArea"><!--a href="#">For Questions About [insert type/label] Contact Us</a>--></div>
<!-- InstanceEndEditable -->
    <div id="content-main">
        <div class="main-inner">
            <!-- ########## CONTENT STARTS HERE ########## -->
             <!-- InstanceBeginEditable name="content-main" -->
                    <div class="syndicate">
                    <div class="mSyndicate">
<div id="archivedbox">

  <p><font color=red>Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: <a href="mailto:mmwrq@cdc.gov">mmwrq@cdc.gov</a>. Type 508 Accommodation and the title of the report in the subject line of e-mail.</font></p>
  
</div>

<h1>Published Reports of Delayed Hemolytic Anemia After Treatment with Artesunate for Severe Malaria &#8212; Worldwide, 2010&#8211;2012</h1>
<!-- this will dynamically write out the report title and date -->
<script language="Javascript" type="text/javascript">
<!--
   var textOut = "";
   if (reportTitle == "MMWR in Brief")
   {
     
	 textOut += '<h2>' +  '<i>' + "MMWR " + '<\/i>' + "in Brief" + '<\/h2>';
   }
   else
   {
	 textOut += '<i><h2>' +  reportTitle + '<\/h2><\/i>';   
   }
   textOut += '<strong>' + reportDate + '<\/strong><br /><br />';
   document.write(textOut);
// -->
</script>

				<p>Artesunate has been recommended by the World Health Organization (WHO) as the first-line treatment for severe malaria since 2010. It is not licensed in the United States but is available from CDC under an investigational new drug (IND) protocol. During 2010&#8211;2012, a total of 19 cases of delayed hemolytic anemia after treatment of severe malaria with artesunate were published in the peer-reviewed medical literature, but no such cases have been reported in the United States. CDC Malaria Branch staff reviewed each published report of delayed hemolysis after artesunate use. Based on the pathogenesis of malaria, the hemolysis likely is a result of severe malaria and not the treatment itself. However, artesunate used in the United States is produced by the U.S. Army Medical Materiel Development Activity, and artesunate used outside of the United States is not. An unrecognized difference might exist between the U.S. artesunate and the artesunate used elsewhere. Alternatively, cases of artesunate-associated hemolysis might have occurred in the United States but were not reported. To better assess these possibilities, CDC has amended the artesunate IND protocol and now recommends that persons treated for severe malaria with artesunate be followed for 4 weeks after treatment and evaluated for hemolytic anemia.</p>
				<p>A literature search was performed using the terms "artesunate" and either "hemolytic anemia" or "delayed anemia." All reports were reviewed, and additional case reports referenced in these reports also were obtained and reviewed. Case reports were considered relevant if the patient had received artesunate therapy for the treatment of severe malaria and then experienced worsening hemolytic anemia after initial clinical improvement and resolution of parasitemia. In total, six articles (describing 19 cases) fit these requirements. One incident of hemolytic anemia was reported in two different articles, one published in 2002 and the other in 2010. Only the 2010 report is included in this summary. </p>
				<p>All cases except one were in adults (median age: 50 years; age range: 5&#8211;71 years) (<span class="callout-pink"><a href="mm6201a2.htm@s_cid=mm6201a2_w.html#tab">Table</a></span>). Eighteen patients had traveled to sub-Saharan Africa, and one to India. All 12 patients with documentation of parasitemia were hyperparasitemic (&gt;5&#37; of red blood cells [RBCs] infected), with a mean highest parasitemia reported of 22&#37; (range: 7&#37;&#8211;45&#37;). Seven of the patients also received artemether-lumefantrine, an oral drug similar to artesunate, for either initial treatment or to complete the treatment regimen. Ten patients received nonartemisinin antimalarials before or after artesunate therapy. All 14 patients for whom multiple hemoglobin measurements were available had a reduction in hemoglobin within the first week of treatment, from a mean of 12.3 g/dL on admission to 8.8 g/dL on follow-up. Seven patients received transfusions with either packed RBCs or platelets during their initial presentation, including three who received exchange transfusions. All patients responded well to artesunate therapy, and complete parasite clearance was documented on average by day 5. </p>
				<p>For all patients, hemolysis and worsening anemia were described after parasite clearance, 8&#8211;32 days after completion of artesunate therapy. The mean hemoglobin nadir was 6.2 g/dL (range: 4.4&#8211;8.6 g/dL) (n = 18). Other reported laboratory measurements supported the diagnosis of hemolysis including elevated lactate dehydrogenase, low or absent haptoglobin, elevated bilirubin, and/or elevated reticulocyte count (n = 12). Twelve patients required transfusions, ranging from 2&#8211;24 units, after artesunate treatment. The hemolysis resolved, and hemoglobin improved in all patients within 4&#8211;8 weeks after artesunate therapy. Two patients had documented moderate anemia more than 30 days after treatment. </p>
				<p>Two studies included information on patients with severe malaria both with and without delayed hemolysis. One reported that the six patients with hemolysis had received a higher mean cumulative dose of artesunate than the 19 patients without hemolysis (12.8 mg/kg versus 7.6 mg/kg) (<i>1</i>). However, the mean cumulative dose in patients with hemolysis in the other article was 7.2 mg/kg, and no correlation between dose and hemolysis was observed (<i>2</i>). Although not specifically discussed, the reported parasitemia in the patients with delayed hemolysis was higher in both studies (mean parasitemia of 16&#37; versus 11&#37;, and median parasitemia of 27&#37; versus 5&#37;, respectively). </p>
				<h3>Reported by</h3>
				<p><i>Melissa Briggs, MD, Paul M. Arguin, MD, Div of Parasitic Diseases and Malaria, Center for Global Health, CDC. </i><b><i>Corresponding contributor: </i></b><i>Melissa Briggs, </i><a href="mailto:vka5@cdc.gov"><i>vka5@cdc.gov</i></a><i>, 404-718-4805. </i></p>
				<h3>Editorial Note</h3>
				<p>This review of published cases found reports of 19 cases of delayed hemolysis after artesunate therapy for severe malaria in nonendemic countries outside of the United States. Thus far, no published studies have assessed whether artesunate actually causes or increases the risk for delayed hemolysis; therefore, it remains unknown whether the hemolysis described is a direct effect of the treatment or simply a consequence of severe malaria itself. </p>
				<p>In 2010, a total of 176 cases of severe malaria in the United States were reported to CDC, 39 (22&#37;) of which were in patients who received artesunate through the CDC IND protocol (<i><a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/ss6102a1.htm?s_cid=ss6102a1_w">3</a></i>). Thus far, delayed hemolytic anemia has not been reported in patients treated with artesunate in the United States. Artesunate has been recommended by WHO as first-line treatment for severe malaria since 2010. It has been shown to be superior to quinine, with increased survival and decreased adverse events (<i>4</i>). Recently, many nonendemic countries have begun to use artesunate in patients with travel-associated severe malaria. The United States is the only country where the artesunate used has been certified as meeting good manufacturing practice (GMP) standards. In all other countries, the only form of artesunate available has not been certified as having been produced according to GMP standards, but has been prequalified by WHO as an essential drug (<i>1,5</i>). WHO prequalification involves a review of safety data and a manufacturing site assessment but is not thought to be as stringent as GMP certification. Various authors have expressed concern that these delayed hemolytic events might be a direct toxicity of the non-GMP artesunate that is currently used outside of the United States (<i>1,2</i>). However, based on this review on malaria and hemolysis, there appear to be more compelling mechanisms that might explain these delayed hemolytic events related to the pathogenesis of severe malaria itself.</p>
				<p>There have been multiple published reports of hemolytic anemia in malaria not associated with artesunate. These include reports of "blackwater fever" (dark red or black urine associated with acute malaria) and prolonged hemolytic anemia in severe malaria patients treated with older antimalarial medications. In 1979, one study showed that circulating RBCs in patients with acute malaria continued to have a decreased life-span for up to 4&#8211;5 weeks after parasite clearance. Patients in this study treated with chloroquine experienced a mean 9&#37; decline in their hemoglobin, occurring 3&#8211;22 days after completion of their treatment. Researchers also detected mild suppression of RBC production and complement-containing immune complexes on RBC surfaces after infection, likely promoting increased splenic removal of RBCs (<i>6</i>). A study conducted in The Gambia showed that patients with severe malaria, but without severe anemia, experienced an initial drop in hemoglobin when started on treatment. In addition, in a subset of children without hemoglobinopathies or glucose-6-phosphate dehydrogenase deficiency (n = 17), 16 were direct antiglobulin test (DAT)&#8211;positive, and nine were positive for immunoglobulin G autoantibodies, with higher parasitemia being associated with increased DAT positivity (<i>7</i>). In 1993, researchers in Germany detected immunoglobulin M antiglycolytic antibodies in patients with severe malaria and prolonged hemolysis after parasite clearance. These antibodies were only present in patients with severe malaria from <i>Plasmodium falciparum</i>, persisted up to &gt;40 days after treatment, and resolved as hemolysis resolved. The typical hemoglobin nadir in this study occurred 6&#8211;12 days postdiagnosis (<i>8</i>). </p>
				<p>In 1997, a study using antibodies against ring-infected erythrocyte surface antigens (RESA) to label <i>P. falciparum</i>&#8211;infected cells found that RBCs with the RESA antigen, but without parasites, could be detected if labeled in vivo. This led to the hypothesis that the spleen or another organ removed or killed the parasites without destroying the RBCs (<i>9</i>). A follow-up study found that, in patients with severe malaria, artesunate treatment generated a much higher number of unparasitized RESA-positive RBCs than quinine. It also noted that artesunate-treated RBCs were more deformable then quinine-treated or parasitized RBCs, likely further extending their lifespan (<i>10</i>). This increase in RBCs surviving after parasitemia, albeit with a shorter lifespan than healthy RBCs, might explain the delayed postartesunate treatment decrease in hemoglobin observed in the cases reported. </p>
				<p>Further comparative data would be required to determine how artesunate influences the risks for this complication, both in travelers and in the increasing proportion of patients receiving artesunate for severe malaria in highly endemic countries. There is insufficient evidence at present to attribute these few reported hemolytic events directly to artesunate treatment itself, and these events should not reduce confidence in artesunate, which has many other benefits for patients with severe malaria. In addition, all patients with reported delayed hemolysis have recovered without long-term complications. However, to further understand the relationship between delayed hemolysis and artesunate use, CDC is requesting that patients treated with artesunate in the United States be evaluated and have their hemoglobin assessed 4 weeks after treatment. Significant declines in hemoglobin should be reported to CDC's Malaria Branch and should prompt an evaluation for hemolysis and closer monitoring. </p>
				<h3>References</h3>
				<ol><li>	Zoller T, Junghanss T, Kapaun A, et al. Intravenous artesunate for severe malaria in travelers, Europe. Emerg Infect Dis 2011;17:771&#8211;7. </li>
				<li>	Kreeftmeijer-Vegter AR, van Genderen PJ, Visser LG, et al. Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium. Malar J 2012;11:102. </li>
				<li>	<a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/ss6102a1.htm?s_cid=ss6102a1_w">CDC. Malaria surveillance&#8212;United States, 2010. MMWR 2012;61(No. SS-2).</a> </li>
				<li>	Dondorp AM, Fanello CI, Hendriksen IC, et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 2010;376:1647&#8211;57. </li>
				<li>	World Health Organization. Prequalification programme: a United Nations programme managed by WHO. Geneva, Switzerland: World Health Organization; 2010. Available at <a href="http://apps.who.int/prequal">http://apps.who.int/prequal</a>. </li>
				<li>	Woodruff AW, Ansdell VE, Pettitt LE. Cause of anaemia in malaria. Lancet 1979;1:1055&#8211;7. </li>
				<li>	Abdalla S, Weatherall DJ, Wickramasinghe SN, Hughes M. The anaemia of <i>P. falciparum</i> malaria. Br J Haematol 1980;46:171&#8211;83.</li>
				<li>	Ritter K, Kuhlencord A, Thomssen R, Bommer W. Prolonged haemolytic anaemia in malaria and autoantibodies against triosephosphate isomerase. Lancet 1993;342:1333&#8211;4. </li>
				<li>	Angus BJ, Chotivanich K, Udomsangpetch R, White NJ. In vivo removal of malaria parasites from red blood cells without their destruction in acute falciparum malaria. Blood 1997;90:2037&#8211;40. </li>
				<li>	Chotivanich K, Udomsangpetch R, Dondorp A, et al. The mechanisms of parasite clearance after antimalarial treatment of <i>Plasmodium falciparum</i> malaria. J Infect Dis 2000;182:629&#8211;33. </li></ol>
			<br />
            <div class="box-frieden">
				<p class="fb-question">What is already known on this topic? </p>
				<p class="fb-answer">Recent reports of delayed hemolytic anemia after artesunate treatment for severe malaria in nonendemic countries other than the United States have generated concern that this phenomenon might be related to the treatment.</p>
				<p class="fb-question">What is added by this report?</p>
				<p class="fb-answer">Published reports describing prolonged hemolytic anemia in severe malaria not associated with artesunate treatment suggest multiple possible causes related to the pathogenesis of severe malaria infection itself. </p>
				<p class="fb-question">What are the implications for public health practice?</p>
				<p class="fb-answer">Additional data are needed. Clinicians treating patients for severe malaria with artesunate should monitor the patient for 4 weeks after treatment, assess for hemolysis if anemia is present, and report any episodes of delayed hemolysis to CDC.</p>
			</div>
            <br />
			<div class="table-story">
				<table id="table-2" class="data-table">
					<tbody>
						<tr>
							<th class="header-row" scope="col" colspan="12">
								<p class="title"><b><a name="tab"></a>TABLE. Articles and cases reported in the literature involving delayed hemolytic anemia after treatment with artesunate, by selected characteristics &#8212; worldwide, 2010&#8211;2012</b></p>
							</th>
						</tr>
						<tr>
							<th class="col-head" scope="col">
								<p class="table-data-8pt-semibold-centered"><b>Case</b></p>
							</th>
							<th class="col-head" scope="col">
								<p class="table-data-8pt-semibold-centered"><b>Location</b></p>
							</th>
							<th class="col-head" scope="col">
								<p class="table-data-8pt-semibold-centered"><b>Case description</b></p>
							</th>
							<th class="col-head" scope="col">
								<p class="table-data-8pt-semibold-centered"><b>Peak parasitemia reported</b></p>
							</th>
							<th class="col-head" scope="col">
								<p class="table-data-8pt-semibold-centered"><b>Initial treatment</b></p>
							</th>
							<th class="col-head" scope="col">
								<p class="table-data-8pt-semibold-centered"><b>Artesunate total dose</b></p>
							</th>
							<th class="col-head" scope="col">
								<p class="table-data-8pt-semibold-centered"><b>Follow-up treatment</b></p>
							</th>
							<th class="col-head" scope="col">
								<p class="table-data-8pt-semibold-centered"><b>Parasite clearance time</b></p>
							</th>
							<th class="col-head" scope="col">
								<p class="table-data-8pt-semibold-centered"><b>Initial Hgb (g/dL)</b></p>
							</th>
							<th class="col-head" scope="col">
								<p class="table-data-8pt-semibold-centered"><b> Hgb nadir (g/dL)</b></p>
							</th>
							<th class="col-head" scope="col">
								<p class="table-data-8pt-semibold-centered"><b>Day of nadir*</b></p>
							</th>
							<th class="col-head" scope="col">
								<p class="table-data-8pt-semibold-centered"><b>Other laboratory findings</b></p>
							</th>
						</tr>
						<tr>
							<td scope="row" class="space-row" colspan="12">
								<p class="table-data-8pt-semibold-left"><b>Rolling T, Schmiedel S, Wichmann D, et al. Post-treatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemia. Malar J 2012;11:169.</b></p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="data-row">
								<p class="table-data-8pt">Case 1</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Germany</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">German female aged 19 yrs with hypotension and hyperparasitemia</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">14&#37;</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Mefloquine</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">8 mg/kg</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Mefloquine</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">5 days</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">12.0</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">8.6</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">14</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">LDH 1,010</p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="data-row">
								<p class="table-data-8pt">Case 2</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Germany</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">German male aged 54 yrs with somnolence, hypotension, hyperbilirubinemia, hyperparasitemia, and acute renal failure</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">21&#37;</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Artesunate</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">9 mg/kg</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Atovaquone/ proguanil</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">7 days</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">NA</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">5.7</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">14</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">LDH increased Haptoglobin absent DAT IgG+</p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="data-row">
								<p class="table-data-8pt">Case 3</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Germany</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">German male aged 55 yrs with fever, acute renal failure, hyperbilirubinemia, and hyperparasitemia</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">20&#37;</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Artesunate</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">9 mg/kg</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Atovaquone/ proguanil</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">NA (&lt;1&#37; on day 3)</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">14.7</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">6.6</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">15</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">LDH increased Haptoglobin absent DAT negative</p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="space-row" colspan="12">
								<p class="table-data-8pt-semibold-left"><b>Kreeftmeijer-Vegter AR, van Genderen PJ, Visser LG. Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium. Malar J 2012;11:102.</b><span class="superscript">&#8224;</span></p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="data-row">
								<p class="table-data-8pt">Case 4</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Netherlands/ Belgium</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Male aged 53 yrs with jaundice, impaired consciousness, and hyperparasitemia</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">34&#37;</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Quinine</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">NA</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Atovaquone/ proguanil</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">4 days</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">12.9</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">6.9</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">20</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">DAT C3d+</p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="data-row">
								<p class="table-data-8pt">Case 5</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Netherlands/ Belgium</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Female aged 50 yrs with impaired consciousness, jaundice, acidosis, renal impairment, and hyperparasitemia</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">19&#37;</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Artesunate</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">NA</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Atovaquone/ proguanil</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">3 days</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">14.0</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">7.0</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">30</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">NA</p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="data-row">
								<p class="table-data-8pt">Case 6</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Netherlands/ Belgium</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Female aged 50 yrs with jaundice and hyperparasitemia</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">11&#37;</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Artesunate</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">NA</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Atovaquone/ proguanil</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">3 days</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">11.4</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">4.5</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">13</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">DAT negative</p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="data-row">
								<p class="table-data-8pt">Case 7</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Netherlands/ Belgium</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Female aged 44 yrs with hyperparasitemia</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">37&#37;</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Quinine</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">NA</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Artemether-lumefantrine</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">4 days</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">9.7</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">6.1</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">15</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">DAT C3d+ IgG+</p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="data-row">
								<p class="table-data-8pt">Case 8</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Netherlands/ Belgium</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Male aged 5 yrs with shock, impaired consciousness, and hyperparasitemia</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">12&#37;</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Quinine</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">NA</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Artemether-lumefantrine</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">4 days</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">9.8</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">6.1</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">8</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">DAT negative Hemacult negative</p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="data-row">
								<p class="table-data-8pt">Case 9</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Netherlands/ Belgium</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Female aged 50 yrs with jaundice, hemoglobinuria, and hyperparasitemia</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">30&#37;</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Artesunate</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">NA</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Artemether-lumefantrine</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">10 days</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">11.6</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">6.9</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">13</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">DAT IgG+ IgM+ Hemacult negative G6PD normal</p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="data-row">
								<p class="table-data-8pt">Case 10</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Netherlands/ Belgium</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Female aged 71 yrs with impaired consciousness, acidosis, hypoglycemia, respiratory distress, renal impairment, and hyperparasitemia</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">20&#37;</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Quinine</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">NA</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Artemether-lumefantrine</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">7 days</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">8.1</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">6.0</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">13</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">DAT negative</p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="space-row" colspan="12">
								<p class="table-data-8pt-semibold-left"><b>Zoller T, Junghanss T, Kapaun A, et al. Intravenous artesunate for severe malaria in travelers, Europe. Emerg Infect Dis 2011;17:771&#8211;7.</b></p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="data-row">
								<p class="table-data-8pt">Case 11</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Europe</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Female aged 30 yrs with hyperparasitemia</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">20&#37;</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Artesunate + doxycycline</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">12 mg/kg</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">None</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">79 hrs</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">11.3</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">5.7</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">15</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">LDH 1,437 Reticulocytes 10.2&#37; DAT negative <br/>G6PD normal</p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="data-row">
								<p class="table-data-8pt">Case 12</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Europe</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Female aged 54 yrs with HIV, admitted with hyperparasitemia and cerebral malaria</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">20&#37;</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Artesunate + doxycycline</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">12 mg/kg</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">None</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">158 hrs</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">13.2</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">6.1</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">32</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">LDH 805</p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="data-row">
								<p class="table-data-8pt">Case 13</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Heidelberg, Germany</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Male aged 32 yrs with hyperparasitemia</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">30&#37;</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Artesunate</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">12 mg/kg</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Atovaquone-proguanil</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">104 hrs</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">13.4</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">5.3</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">19</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">LDH 672</p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="data-row">
								<p class="table-data-8pt">Case 14</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Helsingborg, Sweden</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Male aged 46 yrs with diabetes mellitus admitted with malaria, renal failure, and jaundice</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">4&#37;</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Artesunate</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">20 mg/kg</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">None</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">48 hrs</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">13.4</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">7.8</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">15</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">LDH 660 Reticulocytes increased</p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="data-row">
								<p class="table-data-8pt">Case 15</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Bergen, Norway</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Male aged 49 yrs with renal failure, jaundice, disseminated intravascular coagulation, and hyperparasitemia</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">9&#37;</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Artesunate + doxycycline</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">12 mg/kg</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Artemether-lumefantrine</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">35 hrs</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">15.5</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">5.7</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">15</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">LDH 1,489 Reticulocytes increased Haptglobin &lt;0.1</p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="data-row">
								<p class="table-data-8pt">Case 16</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Europe</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Female aged 34 yrs with renal failure, shock, and hyperparasitemia </p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">10&#37;</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Artesunate + doxycycline</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">10 mg/kg</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Artemether-lumefantrine</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">NA</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">14.2</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">5.8</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">16</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">LDH 444 <br/>Reticulocytes increased Haptoglobin &lt;0.8  G6PD normal</p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="space-row" colspan="12">
								<p class="table-data-8pt-semibold-left"><b>Caramello P, Balbiano R, De Blasi T, et al. Severe malaria, artesunate and haemolysis. J Antimicrob Chemother 2012;67:2053&#8211;4.</b></p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="data-row">
								<p class="table-data-8pt">Case 17</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Italy</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Italian woman aged 22 yrs with fever, splenomegaly, jaundice, and hyperparasitemia</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">7&#37;</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Artemether-lumefantrine</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">NA</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">NA</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">4 days</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">NA</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">5.6</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">13</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">LDH 2,406 DAT negative G6PD normal</p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="space-row" colspan="12">
								<p class="table-data-8pt-semibold-left"><b>Kano S. Artemisinin-based combination therapies and their introduction in Japan. J Infect Chemother 2010;16:375&#8211;82.</b></p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="data-row">
								<p class="table-data-8pt">Case 18</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Japan</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Japanese woman aged 68 yrs</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">45&#37;</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Artesunate</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">NA</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">NA</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">1 day</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">NA</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">NA</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">11</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">NA</p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="data-row">
								<p class="table-data-8pt">Case 19</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Japan</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Japanese man aged 54 yrs</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">NA</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Artesunate</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">NA</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">NA</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">1 day</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">NA</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">4.4</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">15</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">LDH 1,483</p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="footnote-row" colspan="12">
								<p class="footnote-no-indent-7pt"><b>Abbreviations:</b> Hgb = hemoglobin; LDH = lactate dehydrogenase (in U/L); DAT = direct antiglobulin test; G6PD = glucose-6-phosphate dehydrogenase; NA = not available; IgG = immunoglobulin G; IgM = immunoglobulin M.</p>
								<p class="x8pt-footnote-supports-indent-1">*	Day of nadir = days after first dose of artesunate.</p>
								<p class="x8pt-footnote-supports-indent-1"><span class="superscript">&#8224;</span>	Initial Hgb, for this article only, interpreted from published graphs of hemoglobin over time.</p>
							</td>
						</tr>
					</tbody>
				</table>
			</div>
 </div> <!--mSyndicate div end here-->
</div> <!--Syndicate div end here-->
<br /><br />
<div style="clear:left; margin:10px; width:98%; border:1px solid black;"><p><small>Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of 
Health and Human Services. <br /><br />References to non-CDC sites on the Internet are 
provided as a service to <i>MMWR</i> readers and do not constitute or imply 
endorsement of these organizations or their programs by CDC or the U.S. 
Department of Health and Human Services. CDC is not responsible for the content 
of pages found at these sites. URL addresses listed in <i>MMWR</i> were current as of 
the date of publication.</small></p></div><br />
<p><small>All <i>MMWR</i> HTML versions of articles are electronic conversions from typeset documents. 
This conversion might result in character translation or format errors in the HTML version. 
Users are referred to the electronic PDF version (<a href="../../../mmwr.1.html">http://www.cdc.gov/mmwr</a>) 
and/or the original <i>MMWR</i> paper copy for printable versions of official text, figures, and tables. 
An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. 
Government Printing Office (GPO), Washington, DC 20402-9371; 
telephone: (202) 512-1800. Contact GPO for current prices.</small><br /> 
<br />**Questions or messages regarding errors in formatting should be addressed to 
<a href="javascript:sendIt();">mmwrq@cdc.gov</a>.</p>
<!-- InstanceEndEditable -->
                <!-- /end .main-inner --></div>
                <div id="linkPolicy">&nbsp;</div>
            <!-- /end #content-main--></div>
        <!-- /end #content-inner --></div>
<!-- ########## LEFT NAVIGATION STARTS HERE ########## --><!-- This will not display (render off-screen) in the web browser with CSS enabled except for .applicationNav-->
           <div id="nav-container"><!-- InstanceBeginEditable name="left-nav-include" -->
              <div id="nav">
  <h3><a href="../../../mmwr.1.html"><i>MMWR</i> Home</a></h3>
  <ul id="nav-primary">
  
  	 <!-- Dispatch -->
     <!-- li><a href="/mmwr/mmwr_dispatch.html"><i>MMWR</i> Dispatch</a></li -->
 
     <!-- Early Release -->
     <!--li><a href="/mmwr/early_release.html"><i>MMWR</i> Early Release</a></li -->
     <li><a href="https://www.cdc.gov/mmwr/publications/index.html" title="Click for more menu options">Publications</a>
         <ul style="Display:block">
           <li><a href="https://www.cdc.gov/mmwr/index2015.html" title="Click for more menu options">Weekly Report</a>
            <ul>
        	  <li><a href="https://www.cdc.gov/mmwr/mmwr_wk/wk_pvol.html">Past Volumes (1982-2014)</a></li>
            </ul>
           </li>
           <li><a href="https://www.cdc.gov/mmwr/indrr_2015.html" title="Click for more menu options">Recommendations and Reports</a>
            <ul>
         	  <li><a href="https://www.cdc.gov/mmwr/mmwr_rr/rr_pvol.html">Past Volumes (1990-2014)</a></li>
            </ul>
           </li>
           <li><a href="https://www.cdc.gov/mmwr/indss_2015.html" title="Click for more menu options">Surveillance Summaries</a>
            <ul>
         	  <li><a href="https://www.cdc.gov/mmwr/mmwr_ss/ss_pvol.html">Past Volumes (1983-2014)</a></li>
            </ul>
           </li>
           <li><a href="https://www.cdc.gov/mmwr/mmwr_su/index.html">Supplements</a></li>
           <li><a href="https://www.cdc.gov/mmwr/mmwr_nd/index.html">Notifiable Diseases</a></li>
         </ul>  
     </li>
     <!-- li><a href="/mmwr/mmwrsrch.htm"><i>MMWR</i> Advanced Search</a></li -->
     <li><a href="https://www.cdc.gov/mmwr/about.html">About <i>MMWR</i></a></li>
     <li><a href="https://www.cdc.gov/mmwr/Contributors/index.html" title="Click for more menu options">Instructions for Authors</a>
            <ul>
         	  <!-- li><a href="/mmwr/Policy.html">Contributor Attribution Policy</a></li -->
        	  <li><a href="https://www.cdc.gov/mmwr/author_guide_rrss.html">Serial Publications</a></li>
              <li><a href="https://www.cdc.gov/mmwr/author_guide.html">Weekly</a></li>
              <li><a href="https://www.cdc.gov/mmwr/author_guide_ce.html">Continuing Education</a></li>
            </ul>
     </li>
     <li><a href="https://www.cdc.gov/mmwr/cme/conted_info.html" title="Click for more menu options">Continuing Education</a>
         <ul style="Display:block">
           <li><a href="https://www.cdc.gov/mmwr/cme/weekly_conted.html">Weekly Publications</a></li>
           <li><a href="https://www.cdc.gov/mmwr/cme/serial_conted.html">Serial Publications</a></li>
		</ul>
	 </li>
	 <li><a href="https://www.cdc.gov/mmwr/StateHealth/index.html">State Health Statistics</a></li>
     <li><a href="https://www.cdc.gov/mmwr/editorial_board.html"><em>MMWR</em> Editorial Board</a></li>
     <li><a href="https://www.cdc.gov/mmwr/staff/staff.html"><i>MMWR</i> Staff</a></li>
  </ul>
</div>
               <!-- InstanceEndEditable -->
           </div>
       <!-- /end #content --></div>

        <div class="preFoot">
<div id="plugin-legend">
			<h3>File Formats Help:</h3>
			<ul>
				<li class="plugin-pdf"><a href="../../../Other/plugins/index.html#pdf"><img src="../../../TemplatePackage/images/icon_pdf.gif" alt="Adobe PDF file" /></a></li>
				<li class="plugin-word"><a href="../../../Other/plugins/index.html#doc"><img src="../../../TemplatePackage/images/icon_word.gif" alt="Microsoft Word file" /></a></li>
				<li class="plugin-excel"><a href="../../../Other/plugins/index.html#xls"><img src="../../../TemplatePackage/images/icon_excel.gif" alt="Microsoft Excel file" /></a></li>
				<li class="plugin-ppt"><a href="../../../Other/plugins/index.html#ppt"><img src="../../../TemplatePackage/images/icon_ppt.gif" alt="Microsoft PowerPoint file" /></a></li>
				<li class="plugin-wmv"><a href="../../../Other/plugins/index.html#wmv"><img src="../../../TemplatePackage/images/icon_wmv.gif" alt="Audio/Video file" /></a></li>
				<li class="plugin-zip"><a href="../../../Other/plugins/index.html#zip"><img src="../../../TemplatePackage/images/icon_zip.gif" alt="Zip Archive file" /></a></li>
				<li class="plugin-real"><a href="../../../Other/plugins/index.html#ram"><img src="../../../TemplatePackage/images/icon_real.gif" alt="RealPlayer file" /></a></li>
				<li class="plugin-qt"><a href="../../../Other/plugins/index.html#qt"><img src="../../../TemplatePackage/images/icon_qt.gif" alt="Apple Quicktime file" /></a></li>
			</ul>
			<p><a href="../../../Other/plugins/index.html"><span class="tp-label">How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?</span>&nbsp;<img src="../../../TemplatePackage/images/btn_dblArrows.gif" alt="double arrows." /></a></p>
		</div>
           <div class="pageOptions-horizontal">
               <div class="pageOptions-inner2">
                   <ul class="services">
                       <li class="print"><a href="javascript:window.print();">Print</a></li>
<!-- InstanceBeginEditable name="local-options-horizontal" -->
                       <li class="subscribe"><a href="../../../emailupdates/index.html">Updates</a></li>
                       <li class="rss"><a href="../../rss/mmwr.xml" title="Subscribe to MMWR RSS feeds">Subscribe</a></li>
                       <li class="podcast"><a href="../../mmwrpodcasts.html" title="Listen to MMWR podcasts">Listen</a></li>
                    <li><a href="https://www.cdc.gov/mmwr/pdf/wk/mm6201.pdf">Download</a></li>
                    <!-- InstanceEndEditable -->
                    </ul>
                </div>
            </div>
            <!-- InstanceBeginEditable name="include-contactInfo2" -->
            <div class="contactArea"><!--a href="#">For Questions About [insert type/label] Contact Us</a>--></div>
        <!-- InstanceEndEditable -->
			<div id="datestamp"><!-- InstanceBeginEditable name="date-stamp" -->
            <ul>
                <li class="last-reviewed">Page last reviewed: <span>January 11, 2013</span></li>
                <li class="last-updated">Page last updated: <span>January 11, 2013</span></li>
                <li class="content-source">Content source: <a href="../../../index.html">Centers for Disease Control and Prevention</a></li>
            </ul>
        <!-- InstanceEndEditable -->
			</div>
		</div>
		
		<div id="siteinfo">
	<div id="siteinfo-nav">
		<ul class="menu">
			<li><a href="../../../index.html">Home</a></li>
			<li><a href="../../../az/a.html">A-Z Index</a></li>
			<li><a href="../../../Other/policies.html">Policies</a></li>
			<li><a href="../../../Other/about_cdcgov.html">Using this Site</a></li>
			<li><a href="../../../Other/link.html">Link to Us</a></li>
			<li class="last-child"><a href="../../../contact.1.html">Contact CDC</a></li>
		</ul>
	</div>
	<div id="siteinfo-credits">
		<div id="siteinfo-logos"><a href="https://www.usa.gov//"><img id="logo_usagov" src="../../../TemplatePackage/images/logo_usagov.gif" alt="USA.gov: The U.S. Government's Official Web Portal" width="188" height="55" border="0" /></a><a href="https://www.hhs.gov/"><img id="logo_dhhs" src="../../../TemplatePackage/images/logo_dhhs.gif" alt="Department of Health and Human Services" width="61" height="55" border="0" /></a></div>
		<address>Centers for Disease Control and Prevention &nbsp; 1600 Clifton Road Atlanta, GA 30329-4027, USA<br />
		800-CDC-INFO (800-232-4636)	TTY: (888) 232-6348 - <a href="https://wwwn.cdc.gov/dcs/RequestForm.aspx">Contact CDC&ndash;INFO</a></address>
	</div>
</div>

<!--include virtual="/TemplatePackage/3.0/includes/interstitialModal.html" -->
		
		<!-- InstanceBeginEditable name="EditLocalSearch" -->
        <!-- This to make 508 compliance temporay -->
        <!--include virtual="/mmwr/local/B/includes/inc-localSearch_b.html"-->
        <!-- InstanceEndEditable -->
		
		<div id="AZlist-container"><a name="az"></a>
	<span>A-Z Index</span>
	<ol class="AZlist">
		<li><a href="../../../az/a.html">A</a></li>
		<li><a href="../../../az/b.html">B</a></li>
		<li><a href="../../../az/c.html">C</a></li>
		<li><a href="../../../az/d.html">D</a></li>
		<li><a href="../../../az/e.html">E</a></li>
		<li><a href="../../../az/f.html">F</a></li>
		<li><a href="../../../az/g.html">G</a></li>
		<li><a href="../../../az/h.html">H</a></li>
		<li><a href="../../../az/i.html">I</a></li>
		<li><a href="../../../az/j.html">J</a></li>
		<li><a href="../../../az/k.html">K</a></li>
		<li><a href="../../../az/l.html">L</a></li>
		<li><a href="../../../az/m.html">M</a></li>
		<li><a href="../../../az/n.html">N</a></li>
		<li><a href="../../../az/o.html">O</a></li>
		<li><a href="../../../az/p.html">P</a></li>
		<li><a href="../../../az/q.html">Q</a></li>
		<li><a href="../../../az/r.html">R</a></li>
		<li><a href="../../../az/s.html">S</a></li>
		<li><a href="../../../az/t.html">T</a></li>
		<li><a href="../../../az/u.html">U</a></li>
		<li><a href="../../../az/v.html">V</a></li>
		<li><a href="../../../az/w.html">W</a></li>
		<li><a href="../../../az/x.html">X</a></li>
		<li><a href="../../../az/y.html">Y</a></li>
		<li><a href="../../../az/z.html">Z</a></li>
		<li><a href="../../../az/0.html">#</a></li>
	</ol>
</div>

	<!-- /end #wrapper-inner --></div>
	
<!-- /end #wrapper --></div>

<!-- xxxxxxxxxxxxxxxxxx METRICS code begins here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->
<div id="metrics">

<!-- Begin Google DAP inclusion -->
<script type="text/javascript" id="_fed_an_ua_tag" src="../../../JScript/metrics/google/Universal-Federated-Analytics-Min.js@agency=HHS&amp;subagency=CDC"></script>
<!-- End Google DAP inclusion -->

<!-- SiteCatalyst code version: H.21. -->
<script language="JavaScript" type="text/javascript" src="../../../JScript/metrics/topic_levels.js"></script>
<script language="JavaScript" type="text/javascript" src="../../../JScript/metrics/s_code_v21_cdcgov.js"></script>
<script language="JavaScript" type="text/javascript">

<!-- InstanceBeginEditable name="metrics" -->
s.pageName=document.title;
s.channel="MMWR";

<!-- InstanceEndEditable -->
s.prop2=window.location.href;
s.prop26=document.title;
s.prop30=document.title;
s.prop31=window.location.href;
s.prop46=window.location.href;
s.server=window.location.hostname;

// Update the level variables here.
updateVariables(s);

/************* DO NOT ALTER ANYTHING BELOW THIS LINE ! **************/
var s_code=s.t();if(s_code)document.write(s_code);//--></script>
<script language="JavaScript" type="text/javascript"><!--
if(navigator.appVersion.indexOf('MSIE')>=0)document.write(unescape('%3C')+'\!-'+'-');
//--></script><noscript><a href="http://www.omniture.com" title="Web Analytics"><img src="https://smtrics.cdc.gov/b/ss/cdcgov/1/H.21--NS/01/H.21--NS/0" height="1" width="1" border="0" alt="Web Analytics" /></a></noscript><!--/DO NOT REMOVE/-->
<!-- End SiteCatalyst code version: H.21. -->
<!-- Begin Template Package Custom Interactions -->
<script type="text/javascript" src="../../../JScript/metrics/rd_custom_interactions.js"></script>
<!-- End Template Package Custom Interactions -->
<!-- Begin Template Package DigitalGov Search Support -->
<script type="text/javascript" src="../../../JScript/rd_search.js"></script>
<!-- End Template Package DigitalGov Search Support -->
</div>
<!-- xxxxxxxxxxxxxxxxxx METRICS code ends here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->


</body>
<!-- InstanceEnd --></html>